Illegal abortion of female foetuses by some ethnic groups who favour sons has reduced female population
By Keith Perry,
The Telegraph [UK]
| 01. 15. 2014
Sex selection abortions are taking place in some ethnic communities in Britain and the practice is so widespread it has even led to a shortfall in the population of girls, an investigation has revealed.
A Government inquiry last year, following an investigation by the Daily Telegraph that found some doctors were carrying out selective abortions, concluded there was no evidence women living in the UK but born abroad were preferentially aborting girls.
But analysis of data has revealed discrepancies in the sex ratio of children in some immigrant families, suggesting sex selective abortions must be taking place.
The investigation by the Independent analysed data from the 2011 census and the Office for National Statistics (ONS) to test whether having a daughter as a first child increases the chances of the second child being a boy.
Experts from Imperial College said while some of the data could be explained by the 'don't stop until you get a boy' practice, this could not explain all the findings from families of mothers born in Pakistan and Afghanistan and living in the UK.
Selective...
Related Articles
By Timnit Gebru and Émile P. Torres, First Monday | 04.14.2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can...
By Harold Brubaker, The Philadelphia Inquirer | 04.04.2024
Acompany started by University of Pennsylvania scientist Jim Wilson has received FDA approval to test a form of gene editing in infants for the first time in the United States, the company said Thursday.
The Plymouth Meeting company, iECURE, is...
By Jason Kehe, Wired | 04.11.2024
God help the babies! Or, absent God, a fertility startup called Orchid. It offers prospective parents a fantastical choice: Have a regular baby or have an Orchid baby. A regular baby might grow up and get cancer. Or be born...
By Nick Paul Taylor, BioSpace | 03.14.2024
A U.K. watchdog balked at the cost-effectiveness of Vertex Pharmaceuticals’ CRISPR-based sickle cell disease therapy Thursday, recommending against funding the treatment unless uncertainties can be cleared up satisfactorily.
The U.K. became the first country to authorize Vertex’s Casgevy (exagamglogene...